AbCellera Biologics Statistics
NASDAQ: ABCLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
9.69-0.78 (-7.45%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
AbCellera Biologics by the numbers
AbCellera Biologics has a market capitalization of $3.16 billion based on 326.62M shares outstanding. With trailing EPS of $-0.48, AbCellera Biologics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.2% below its 50-day average and 30.6% above its 200-day average.
Average daily trading volume is 4.34M shares, or about $42.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABCL valuation vs. peer median
| Metric | ABCL | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.16B | $3.13B | +1% |
| Avg. volume | 4.34M | 2.42M | +79% |
Peer median across 8 companies: VKTX, XERS, BHC, ARQT, AMLX, LEGN, ACAD, VRDN.
Valuation
- Market cap
- $3.16B
- Price / sales (latest FY)
- 42.13
- EPS (TTM)
- $-0.48
- Shares outstanding
- 326.62M
Price and trading
- Previous close
- 10.47
- Open
- 10.10
- Day range
- 9.58 – 10.26
- 52-week range
- 2.75 – 15.02
- 52-week change
- +176.07%
- Beta
- —
- Volume
- 4.24M
- Average volume
- 4.34M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 3.16B
- Forward Pe
- -13.77
- Eps
- -0.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.02
- Week52 Low
- 2.75
- Avg Volume
- 4.34M
- Shares Outstanding
- 326.62M
- Ma50
- 12.30
- Ma200
- 7.42
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -35.46%
- Pct From52w Low
- 253.01%